322 related articles for article (PubMed ID: 8512596)
1. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
[TBL] [Abstract][Full Text] [Related]
2. 4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors.
Saraswati M; Hashmi M; Abood LG
Neurochem Res; 1992 Mar; 17(3):247-52. PubMed ID: 1620268
[TBL] [Abstract][Full Text] [Related]
3. [3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors.
Abood LG; Grassi S
Biochem Pharmacol; 1986 Dec; 35(23):4199-202. PubMed ID: 3790148
[TBL] [Abstract][Full Text] [Related]
4. Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors.
Søkilde B; Mikkelsen I; Stensbøl TB; Andersen B; Ebdrup S; Krogsgaard-Larsen P; Falch E
Arch Pharm (Weinheim); 1996 Feb; 329(2):95-104. PubMed ID: 8851473
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.
Anderson DJ; Arneric SP
Eur J Pharmacol; 1994 Mar; 253(3):261-7. PubMed ID: 8200419
[TBL] [Abstract][Full Text] [Related]
7. Alterations in muscarinic cholinergic receptors after preganglionic denervation of the superior cervical ganglion in cats.
Taniguchi T; Kurahashi K; Fujiwara M
J Pharmacol Exp Ther; 1983 Mar; 224(3):674-8. PubMed ID: 6827488
[TBL] [Abstract][Full Text] [Related]
8. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
9. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
[TBL] [Abstract][Full Text] [Related]
10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
11. Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes.
Wang DX; Lerner-Marmarosh N; Sheu SS; Sharma V; Jou MJ; Abood LG
Pharmacol Biochem Behav; 1994 Oct; 49(2):405-11. PubMed ID: 7824557
[TBL] [Abstract][Full Text] [Related]
12. Differential distribution of muscarinic cholinergic and putative nicotinic cholinergic receptors within the hypothalamo-neurohypophysial system of the rat.
Michels KM; Meeker RB; Hayward JN
Neuroendocrinology; 1986; 44(4):498-507. PubMed ID: 3822079
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic localization of nicotinic receptor binding in rat brain using [3H]methylcarbamylcholine, a novel radioligand.
Yamada S; Gehlert DR; Hawkins KN; Nakayama K; Roeske WR; Yamamura HI
Life Sci; 1987 Dec; 41(26):2851-61. PubMed ID: 3695812
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of muscarinic and nicotinic receptors by cholinergic stimulation in cultured avian retina cells.
Siman RG; Klein WL
Brain Res; 1983 Feb; 262(1):99-108. PubMed ID: 6831232
[TBL] [Abstract][Full Text] [Related]
15. Studies of muscarinic and nicotinic binding sites in brain.
Nordberg A; Larsson C
Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic cholinergic receptors in human foetal brain: characterization and ontogeny of [3H]quinuclidinyl benzilate binding sites in frontal cortex.
Ravikumar BV; Sastry PS
J Neurochem; 1985 Jan; 44(1):240-6. PubMed ID: 3964831
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.
Lockhart B; Closier M; Howard K; Steward C; Lestage P
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):429-38. PubMed ID: 11330337
[TBL] [Abstract][Full Text] [Related]
18. Interaction of choline with nicotinic and muscarinic cholinergic receptors in the rat brain in vitro.
Costa LG; Murphy SD
Clin Exp Pharmacol Physiol; 1984; 11(6):649-54. PubMed ID: 6536422
[TBL] [Abstract][Full Text] [Related]
19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
20. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
Taniguchi T; Tsukahara T; Fujiwara M
Life Sci; 1983 Apr; 32(15):1757-63. PubMed ID: 6835022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
